Ciclesonide
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Perennial Allergic Rhinitis
Conditions
Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever
Trial Timeline
Dec 1, 2003 → Apr 1, 2005
NCT ID
NCT00163501About Ciclesonide
Ciclesonide is a phase 3 stage product being developed by AstraZeneca for Perennial Allergic Rhinitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00163501. Target conditions include Perennial Allergic Rhinitis, Allergic Rhinitis, Hay Fever.
What happened to similar drugs?
14 of 20 similar drugs in Perennial Allergic Rhinitis were approved
Approved (14) Terminated (1) Active (6)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (19)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01455194 | Phase 3 | Completed |
| NCT00608218 | Pre-clinical | Completed |
| NCT00305461 | Phase 3 | Completed |
| NCT00261287 | Phase 3 | Completed |
| NCT00163371 | Phase 3 | Completed |
| NCT00163436 | Phase 3 | Completed |
| NCT00163488 | Phase 3 | Completed |
| NCT00163423 | Phase 3 | Completed |
| NCT00163319 | Phase 3 | Completed |
| NCT00163462 | Phase 3 | Completed |
| NCT00163514 | Phase 3 | Completed |
| NCT00163384 | Phase 3 | Completed |
| NCT00163397 | Phase 3 | Completed |
| NCT00163501 | Phase 3 | Completed |
| NCT00163345 | Phase 3 | Completed |
| NCT00163358 | Phase 3 | Completed |
| NCT00163410 | Phase 3 | Completed |
| NCT00163332 | Phase 3 | Completed |
| NCT00546520 | Phase 3 | Completed |
Competing Products
20 competing products in Perennial Allergic Rhinitis